Truist Securities raises Revolution Medicines target price to $240 from $239
RVMD•Truist Securities raised its target price for Revolution Medicines to $240 from $239.
Related News
H&P expands FlexRobotics deployment with ExxonMobil to nine systems
HP•
Skyworks Solutions price objective raised to $78 from $65
SWKS•
WillScot elects Donald Slager to board of directors
WSC•
Tennessee Gas Pipeline lifts force majeure at STA 409A-101 to MLV 409A-103
KMI•
ERock signs multi-year engine supply deal with Hyundai unit HD Construction Equipment
EROC•